PI 3 Kinase p85 alpha Recombinant Rabbit Monoclonal Antibody [SU04-07]
Usd: 385 Special Discount
Specification
Safety datasheet
Overview
Product Name
PI 3 Kinase p85 alpha Recombinant Rabbit Monoclonal Antibody [SU04-07]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within C-terminal human PI 3 Kinase p85 alpha.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, IF-Tissue, IHC-P, FC
Molecular Weight
Predicted band size: 84 kDa
Positive Control
HepG2 cell lysate, Jurkat cell lysate, MCF7 cell lysate, NIH/3T3 cell lysate, C6 cell lysate, Mouse brain tissue lysate, Rat brain tissue lysate, Hela, MCF-7, HepG2, NIH/3T3, human brain tissue, human lung tissue, mouse lung tissue, rat lung tissue.
Conjugation
unconjugated
Clone Number
SU04-07
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000-1:5,000
-
IF-Cell
-
1:50-1:200
-
IF-Tissue
-
1:50-1:200
-
IHC-P
-
1:50-1:1,000
-
FC
-
1:50-1:100
Target
Function
Phosphatidylinositol 3-kinase (PI 3-kinase) phosphorylates the 3' OH position of the inositol ring of inositol lipids and is composed of p85 and p110 subunits. PI 3-kinase p85 lacks PI 3-kinase activity and acts as an adapter, coupling p110 to activated protein tyrosine kinase. Two forms of p85 have been described (p85α and p85β), each possessing one SH3 and two SH2 domains. PI 3-kinase p85α, also known as GRB1, phosphatidylinositol 3-kinase regulatory 1 or p85, is a 724 amino acid protein that exists as four alternatively spliced isoforms. Involved in insulin metabolism, defects in the PI 3-kinase p85α gene have been linked to insulin resistance. PI 3-kinase p85α is polyubiquitinated in T-cells by Cbl-b, and has multiple phosphorylated amino acid residues, including a phosphorylated tyrosine residue at position 467.
Background References
1. Yan LX et al. PIK3R1 targeting by miR-21 suppresses tumor cell migration and invasion by reducing PI3K/AKT signaling and reversing EMT, and predicts clinical outcome of breast cancer. Int J Oncol 48:471-84 (2016).
2. Hu J et al. Filamin B regulates chondrocyte proliferation and differentiation through Cdk1 signaling. PLoS One 9:e89352 (2014).
Sequence Similarity
Belongs to the PI3K p85 subunit family.
Tissue Specificity
Isoform 2 is expressed in skeletal muscle and brain, and at lower levels in kidney and cardiac muscle. Isoform 2 and isoform 4 are present in skeletal muscle (at protein level).
Post-translational Modification
Polyubiquitinated in T-cells by CBLB; which does not promote proteasomal degradation but impairs association with CD28 and CD3Z upon T-cell activation.; Phosphorylated. Tyrosine phosphorylated in response to signaling by FGFR1, FGFR2, FGFR3 and FGFR4. Phosphorylated by CSF1R. Phosphorylated by ERBB4. Phosphorylated on tyrosine residues by TEK/TIE2. Dephosphorylated by PTPRJ. Phosphorylated by PIK3CA at Ser-608; phosphorylation is stimulated by insulin and PDGF. The relevance of phosphorylation by PIK3CA is however unclear (By similarity). Phosphorylated in response to KIT and KITLG/SCF. Phosphorylated by FGR.
Subcellular Location
Cytoplasm, membrane, nucleus.
Synonyms
GRB1 antibody
p85 alpha antibody
p85 antibody
P85A_HUMAN antibody
Phosphatidylinositol 3 kinase associated p 85 alpha antibody
Phosphatidylinositol 3 kinase regulatory 1 antibody
Phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 1 (p85 alpha) antibody
Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha antibody
Phosphatidylinositol 3-kinase regulatory subunit alpha antibody
Phosphoinositide 3 kinase, regulatory subunit 1 (alpha) antibody
ExpandGRB1 antibody
p85 alpha antibody
p85 antibody
P85A_HUMAN antibody
Phosphatidylinositol 3 kinase associated p 85 alpha antibody
Phosphatidylinositol 3 kinase regulatory 1 antibody
Phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 1 (p85 alpha) antibody
Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha antibody
Phosphatidylinositol 3-kinase regulatory subunit alpha antibody
Phosphoinositide 3 kinase, regulatory subunit 1 (alpha) antibody
PI3 kinase p85 subunit alpha antibody
PI3-kinase regulatory subunit alpha antibody
PI3-kinase subunit p85-alpha antibody
PI3K antibody
PI3K regulatory subunit alpha antibody
Pik3r1 antibody
PtdIns 3 kinase p85 alpha antibody
PtdIns-3-kinase regulatory subunit alpha antibody
PtdIns-3-kinase regulatory subunit p85-alpha antibody
CollapseImages
-
Western blot analysis of PI 3 Kinase p85 alpha on different lysates with Rabbit anti-PI 3 Kinase p85 alpha antibody (ET1608-70) at 1/5,000 dilution.
Lane 1: HepG2 cell lysate (20 µg/Lane)
Lane 2: Jurkat cell lysate (20 µg/Lane)
Lane 3: MCF7 cell lysate (20 µg/Lane)
Lane 4: NIH/3T3 cell lysate (20 µg/Lane)
Lane 5: C6 cell lysate (20 µg/Lane)
Lane 6: Mouse brain tissue lysate (40 µg/Lane)
Lane 7: Rat brain tissue lysate (40 µg/Lane)
Predicted band size: 84 kDa
Observed band size: 84 kDa
Exposure time: 1 minute; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1608-70) at 1/5,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
ICC staining of PI 3 Kinase p85 alpha in Hela cells (red). Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 1% Blocker BSA for 15 minutes at room temperature. Cells were probed with the primary antibody (ET1608-70, 1/50) for 1 hour at room temperature, washed with PBS. Alexa Fluor®594 Goat anti-Rabbit IgG was used as the secondary antibody at 1/1,000 dilution. The nuclear counter stain is DAPI (blue).
-
ICC staining of PI 3 Kinase p85 alpha in MCF-7 cells (red). Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 1% Blocker BSA for 15 minutes at room temperature. Cells were probed with the primary antibody (ET1608-70, 1/50) for 1 hour at room temperature, washed with PBS. Alexa Fluor®594 Goat anti-Rabbit IgG was used as the secondary antibody at 1/1,000 dilution. The nuclear counter stain is DAPI (blue).
-
ICC staining of PI 3 Kinase p85 alpha in HepG2 cells (red). Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 1% Blocker BSA for 15 minutes at room temperature. Cells were probed with the primary antibody (ET1608-70, 1/50) for 1 hour at room temperature, washed with PBS. Alexa Fluor®594 Goat anti-Rabbit IgG was used as the secondary antibody at 1/1,000 dilution. The nuclear counter stain is DAPI (blue).
-
ICC staining of PI 3 Kinase p85 alpha in NIH/3T3 cells (red). Formalin fixed cells were permeabilized with 0.1% Triton X-100 in TBS for 10 minutes at room temperature and blocked with 1% Blocker BSA for 15 minutes at room temperature. Cells were probed with the primary antibody (ET1608-70, 1/50) for 1 hour at room temperature, washed with PBS. Alexa Fluor®594 Goat anti-Rabbit IgG was used as the secondary antibody at 1/1,000 dilution. The nuclear counter stain is DAPI (blue).
-
Immunohistochemical analysis of paraffin-embedded human brain tissue with Rabbit anti-PI 3 Kinase p85 alpha antibody (ET1608-70) at 1/200 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-70) at 1/200 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human lung tissue with Rabbit anti-PI 3 Kinase p85 alpha antibody (ET1608-70) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-70) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded mouse lung tissue with Rabbit anti-PI 3 Kinase p85 alpha antibody (ET1608-70) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-70) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded rat lung tissue with Rabbit anti-PI 3 Kinase p85 alpha antibody (ET1608-70) at 1/1,000 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-70) at 1/1,000 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Flow cytometric analysis of PI 3 Kinase p85 alpha was done on HepG2 cells. The cells were fixed, permeabilized and stained with the primary antibody (ET1608-70, 1/50) (red). After incubation of the primary antibody at room temperature for an hour, the cells were stained with a Alexa Fluor 488-conjugated Goat anti-Rabbit IgG Secondary antibody at 1/1000 dilution for 30 minutes.Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
An Engineered Extracellular Vesicle With Enhanced Tumor and Lymph Nodes Targeting as siRNA Delivery System for Robust Tumor Immunotherapy
Journal: Medicine And Communication
DOI: 10.1002/mco2.70673
IF: 10.7
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
Methylophiopogonanone a attenuates pulmonary fibrosis by inhibiting SPP1-mediated macrophage polarization via the PI3K/Akt pathway
Journal: Animal Models And Experimental Medicine
DOI: 10.1002/ame2.70157
IF: 3.4
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
Nobiletin enhances Doxorubicin sensitivity in osteosarcoma through ER stress-induced apoptosis mediated by the PI3K/AKT pathway
Journal: Scientific Reports
DOI: 10.1038/s41598-026-44757-1
IF: 3.9
Application: WB
Reactivity: Human
Publish date: 2026 Mar
-
Agarononaose from red algae delays cardiomyocyte aging by improving mitochondrial function via enhanced oxidative phosphorylation: A mitochondrial transplantation perspective
Journal: Journal Of Functional Foods
DOI: 10.1016/j.jff.2025.107131
IF: 4
Application: WB
Reactivity: Mouse
Publish date: 2026 Jan
-
The PI3K/AKT/NRF2 Signaling Pathway Involved in the Improvement of CUMS-Induced Depressive-like Behaviors by Apigenin
Journal: Pharmaceuticals
DOI: 10.3390/ph19020195
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2026 Jan
-
An H₂S-releasing oridonin derivative protects HaCaT cells against metabolic stress via PI3K/AKT/Nrf2 signaling
Journal: Molecular Immunology
DOI: 10.1016/j.molimm.2025.12.012
IF: 3
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Indirubin treatment was associated with modulation of the PI3K/AKT and MAPK pathways and induction of apoptosis and autophagy
Journal: Scientific Reports
DOI: 10.1038/s41598-026-35382-z
IF: 3.9
Application: WB
Reactivity: Human
Publish date: 2026 Jan
-
Effects of Dietary Peptides From Essence of Chicken on Neuroinflammation and Their Synergism in Neuroprotection
Journal: International Journal for Vitamin and Nutrition Research
DOI: 10.31083/IJVNR45261
IF: 2.5
Application: WB
Reactivity: Mouse
Publish date: 2026 Jan
-
Spatiotemporally Controllable In Situ Hydrogels Enabled by Nanobottle-Mediated Encapsulation Technology for Stage-Specific Synergistic Therapy of Osteoarthritis
Journal: Advanced Functional Materials
DOI: 10.1002/adfm.202531767
IF: 19
Application: WB
Reactivity: Rat
Publish date: 2026 Feb
-
Exploring the intervention mechanism of Acori Tatarinowii Rhizoma-Polygalae Radix herb pair on post-stroke depression based on multi-omics analysis
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2026.121440
IF: 5.4
Application: WB
Reactivity: Rat
Publish date: 2026 Feb
-
Integration of network pharmacology and experimental verification to reveal the active constituents and molecular mechanism of Compound Fujin Shengji (FJSJ) Powder in the treatment of diabetes ulcer
Journal: Chinese Journal of Analytical Chemistry
DOI: 10.1016/j.cjac.2025.100624
IF: 1.3
Application: WB
Reactivity: Human
Publish date: 2025 Sept
-
Bifidobacterium longum subsp. longum B-53 Alleviated Abnormalities of Glycolipid Metabolism and Oxidative Stress in T2DM Mice Through Regulating Gut Microbiota and GLP-1 Secretion
Journal: Journal Of Agricultural And Food Chemistry
DOI: 10.1021/acs.jafc.5c07346
IF: 6.2
Application: WB
Reactivity: Mouse
Publish date: 2025 Sept
-
Atractylenolide III Alleviates Inflammation in Cerebral Ischemia/Reperfusion Injury by Modulating the PI3K/Akt/NF-κB Signaling Pathway
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2025.120644
IF: 5.4
Application: WB
Reactivity: Rat
Publish date: 2025 Sept
-
ATP6V0D2 drives triple-negative breast cancer progression and inhibits cisplatin sensitivity by promoting PHLPP2 lysosomal degradation
Journal: iScience
DOI: 10.1016/j.isci.2025.113853
IF: 4.1
Application: WB
Reactivity: Human
Publish date: 2025 Oct
-
Mechanical Stretch Prevents Senescence-Associated Osteogenic Impairment in Mesenchymal Stem Cells via CXCR4/PI3K/AKT Signaling
Journal: FASEB Journal
DOI: 10.1096/fj.202500239R
IF: 4.2
Application: WB
Reactivity: Mouse
Publish date: 2025 Oct
-
RAD23B Promotes Colorectal Cancer Metastasis via the Talin1/Integrin/PI3K/AKT/MMP9 Axis
Journal: Oncology Research
DOI: 10.32604/or.2025.067535
IF: 4.1
Application: WB
Reactivity: Human
Publish date: 2025 Oct
-
CUEDC1 promotes glycolytic metabolism reprogramming through the CUEDC1/CACNG4/PI3K axis to promote ER-positive breast cancer growth
Journal: Cellular & Molecular Biology Letters
DOI: 10.1186/s11658-025-00819-2
IF: 10.2
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Paeoniflorin Alleviates LPS-Induced Inflammation and Acute Myocardial Injury by Inhibiting PI3K/Akt/ERK-Mediated HIF-1α and TLR4/MyD88/NF-κB Inflammatory Signaling
Journal: Mediators of Inflammation
DOI: 10.1155/mi/2346163
IF: 4.2
Application: WB
Reactivity: Rat
Publish date: 2025 Nov
-
1,2,3-Triazole-modified sorafenib derivatives induce DNA damage, apoptosis, and PI3K/AKT pathway suppression in hepatocellular carcinoma: Design, synthesis, and evaluation
Journal: Bioorganic Chemistry
DOI: 10.1016/j.bioorg.2025.109210
IF: 4.7
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Metalloporphyrin organic framework oxygen-generators enable tumour-targeted photodynamic therapy and metabolic reprogramming for enhanced glioblastoma treatment
Journal: Journal of Colloid and Interface Science
DOI: 10.1016/j.jcis.2025.139521
IF: 9.7
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Conjugating 10,11-Dimethoxy-camptothecin with an Integrin αvβ3-Targeting Peptide through a Triazine Linker for Targeted Tumor Treatment in Lung and Pancreatic Carcinoma
Journal: Journal Of Medicinal Chemistry
DOI: 10.1021/acs.jmedchem.5c02059
IF: 6.8
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
OpiCa1 Modulates Cardiomyocyte Viability Through PI3K/Akt Inhibition with Minimal Systemic Impact Beyond RyR Targeting
Journal: Toxins
DOI: 10.3390/toxins17110550
IF: 4
Application: WB
Reactivity: Mouse,Rat
Publish date: 2025 Nov
-
Highly Soluble Mussel Foot Protein Enhances Antioxidant Defense and Cytoprotection via PI3K/Akt and Nrf2/HO-1 Pathways
Journal: Antioxidants
DOI: 10.3390/antiox14060644
IF: 6
Application: WB
Reactivity: Mouse
Publish date: 2025 May
-
Ruminococcus bromii-generated acetate alleviated Clonorchis sinensis-induced liver fibrosis in mice
Journal: Frontiers in Microbiology
DOI: 10.3389/fmicb.2025.1532599
IF: 4.5
Application: WB
Reactivity: Mouse
Publish date: 2025 Mar
-
Astragalus membranaceus extract attenuates ulcerative colitis by integrating multiomics and the PI3K/AKT signaling pathway
Journal: Frontiers In Pharmacology
DOI: 10.3389/fphar.2025.1585748
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2025 Jun
-
A novel PEGylated squid-derived protamine protein in combination with sorafenib effectively inhibits hepatocellular carcinoma growth
Journal: International Journal Of Biological Macromolecules
DOI: 10.1016/j.ijbiomac.2025.145283
IF: 8.5
Application: WB
Reactivity: Mouse
Publish date: 2025 Jun
-
Biomaterial-Based Lymphangiogenesis-Enhanced Therapeutic Strategy for Robustly-Integrated Medication-Related Osteonecrosis of Jaw Prevention
Journal: ACS Applied Materials & Interfaces
DOI: 10.1021/acsami.5c02812
IF: 8.2
Application: WB
Reactivity: Human
Publish date: 2025 Jun
-
Exosomal SPRY4 from adipogenic BMSCs impairs angiogenesis via the PTPRB/TIE2/PI3K axis in Steroid-induced osteonecrosis of the femoral head
Journal: Stem Cell Research & Therapy
DOI: 10.1186/s13287-025-04505-0
IF: 7.3
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
The Mechanosensitive Ion Channel Piezo1 Regulates Chondrocyte Homeostasis Through the PI3K/AKT/mTORC1 Pathway in Osteoarthritis
Journal: Journal Of Cellular And Molecular Medicine
DOI: 10.1111/jcmm.70734
IF: 4.2
Application: WB
Reactivity: Rat
Publish date: 2025 Jul
-
Exploring SERTAD4 as a prognostic biomarker and therapeutic target in breast cancer: insights from multidatabase analyses and in vitro studies
Journal: Clinical And Experimental Medicine
DOI: 10.1007/s10238-025-01792-y
IF: 3.5
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
NACC1 accelerates the progression of AML by regulating the ADAM9/PI3K/AKT axis
Journal: International Journal Of Medical Sciences
DOI:
IF: 3.2
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
Investigation of Substance Basis and Pharmacodynamics of Qingzao Jiefei Decoction in Lung Cancer based on Serum Pharmacochemistry and Proteomics
Journal: Chemistry & Biodiversity
DOI:
IF: 2.3
Application: WB
Reactivity: Mouse
Publish date: 2025 Jan
-
Investigation of Substance Basis and Pharmacodynamics of Qingzao Jiefei Decoction in Lung Cancer based on Serum Pharmacochemistry and Proteomics
Journal: CHEMISTRY & BIODIVERSITY
DOI: 10.1002/cbdv.202402774
IF: 2.5
Application: WB
Reactivity: Mouse
Publish date: 2025 Jan
-
NACC1 accelerates the progression of AML by regulating the ADAM9/PI3K/AKT axis
Journal: International Journal of Medical Sciences
DOI: 10.7150/ijms.102266
IF: 3.2
Application: WB
Reactivity: Human
Publish date: 2025 Jan
-
Hespintor Negative Regulation of PI3K/Akt Pathway Induces Cell Cycle Arrest of Hepatocellular Carcinoma
Journal: Bulletin Of Experimental Biology And Medicine
DOI:
IF: 0.9
Application: WB
Reactivity: Mouse
Publish date: 2025 Jan
-
Hespintor Negative Regulation of PI3K/Akt Pathway Induces Cell Cycle Arrest of Hepatocellular Carcinoma
Journal: BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
DOI: 10.1007/s10517-025-06314-0
IF: 0.6
Application: WB
Reactivity: Mouse
Publish date: 2025 Jan
-
Betulinic Acid Inhibits Glioma Progression by Inducing Ferroptosis Through the PI3K/Akt and NRF2/HO-1 Pathways
Journal: Journal Of Gene Medicine
DOI: 10.1002/jgm.70011
IF: 3.2
Application: WB
Reactivity: Human
Publish date: 2025 Feb
-
Isorhamnetin Alleviates Inflammation-Induced Crosstalk between Kynurenine Pathway and Gut Microbiota in Depressed Mice
Journal: Biomolecules & Therapeutics
DOI: 10.4062/biomolther.2024.061
IF: 3
Application: WB
Reactivity: Mouse
Publish date: 2025 Feb
-
Total flavonoids extracted from the leaves of Murraya paniculata (L.) Jack prevents acetaminophen-induced liver injury by activating Keap1/Nrf2 and PI3K/AKT/mTOR signaling pathway
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2025.119562
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2025 Feb
-
Therapeutic Intervention of Corticospinal Tract Sprouting after Unilateral Traumatic Brain Injury via METTL1-Mediated tRNA m7G Modification
Journal: Molecular Neurobiology
DOI: 10.1007/s12035-025-05599-6
IF: 4.3
Application: WB
Reactivity: Mouse
Publish date: 2025 Dec
-
ACAT1 inhibitor Avasimibe suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via CKB/PI3K-AKT signaling
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2025.115973
IF: 4.7
Application: WB
Reactivity: Mouse
Publish date: 2025 Dec
-
Integrating network pharmacology and experimental validation to explore the mechanism of Yiqi Ziyin in treating immune thrombocytopenia
Journal: Scientific Reports
DOI: 10.1038/s41598-025-14105-w
IF: 3.9
Application: WB
Reactivity: Mouse
Publish date: 2025 Aug
-
Neomycin affects cardiovascular and hematopoietic system via the PI3K/Akt pathway in zebrafish larvae
Journal: Ecotoxicology And Environmental Safety
DOI: 10.1016/j.ecoenv.2025.118203
IF: 6.2
Application: WB
Reactivity: Zebrafish
Publish date: 2025 Apr
-
The ultrafine powder of atractylodis macrocephalae rhizoma improves immune function in naturally aging rats by regulating the PI3K/Akt/NF-κB signaling pathway
Journal: Frontiers In Pharmacology
DOI: 10.3389/fphar.2025.1550357
IF: 4.4
Application: WB
Reactivity: Rat
Publish date: 2025 Apr
-
Effects of anlotinib hydrochloride on the expression of immunogenic cell death-related molecules in Cal27 tongue cancer cells
Journal:
DOI: 10.1007/s12672-025-02464-9
IF:
Application: WB
Reactivity: Mouse
Publish date: 2025 Apr
-
Ferulic Acid Methyl Ester Attenuates Cerebral Ischemia-Reperfusion Injury in Rats by Modulating PI3K/HIF-1α/VEGF Signaling Pathway
Journal: Journal Of Inflammation Research
DOI:
IF: 4.2
Application: WB
Reactivity: Rat
Publish date: 2024 Sep
-
Genipin promotes the apoptosis and autophagy of neuroblastoma cells by suppressing the PI3K/AKT/mTOR pathway
Journal: Scientific Reports
DOI:
IF: 3.8
Application: WB
Reactivity: Human
Publish date: 2024 Sep
-
CORO1C Regulates the Malignant Biological Behavior of Ovarian Cancer Cells and Modulates the mRNA Expression Profile through the PI3K/AKT Signaling Pathway
Journal: Cell Biochemistry And Biophysics
DOI:
IF: 4.2
Application: WB
Reactivity: Human
Publish date: 2024 Oct
-
Microenvironment-responsive injectable hydrogel for neuro-vascularized bone regeneration
Journal: Materials Today Bio
DOI:
IF:
Application: WB
Reactivity: Rat
Publish date: 2024 Nov
-
Exploring the Osteogenic Effects of Simiao Wan through Activation of the PI3K/AKT Pathway in Osteoblasts
Journal: Journal Of Ethnopharmacology
DOI:
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2024 Nov
-
Ruminococcus bromii-generated acetate alleviated Clonorchis sinensis-induced liver fibrosis in mice
Journal: Research Square
DOI:
IF:
Application: WB
Reactivity: Mouse
Publish date: 2024 Nov
-
Network pharmacology to unveil the mechanism of Astragali Radix in the treatment of lupus nephritis via PI3K/AKT/mTOR pathway
Journal: Scientific Reports
DOI:
IF: 3.8
Application: WB
Reactivity: Human
Publish date: 2024 Nov
-
Sr-Incorporated Bioactive Glass Remodels the Immunological Microenvironment by Enhancing the Mitochondrial Function of Macrophage via the PI3K/AKT/mTOR Signaling Pathway
Journal: ACS Biomaterials Science & Engineering
DOI:
IF: 5.7
Application: WB
Reactivity: Rat
Publish date: 2024 May
-
Cell surface patching via CXCR4-targeted nanothreads for cancer metastasis inhibition
Journal: Nature Communications
DOI:
IF: 16.6
Application: FC
Reactivity: Mouse
Publish date: 2024 Mar
-
Engineered-Doping Strategy for Self-Sufficient Reactive Oxygen Species Blossom to Amplify Ferroptosis/Cuproptosis Sensibilization in Hepatocellular Carcinoma Treatment
Journal: Advanced Functional Materials
DOI:
IF: 19.9
Application: WB
Reactivity: Human
Publish date: 2024 Jun
-
Inhibiting PRMT1 protects against CoNV by regulating macrophages through the FGF2/PI3K/Akt pathway
Journal: European Journal Of Pharmacology
DOI:
IF: 5
Application: WB
Reactivity: Mouse
Publish date: 2024 Jun
-
The Therapeutic Potential of Chi Shao and Fu Zi in Acute-on-Chronic Liver Failure: Insights from Network Pharmacology and Animal Studies
Journal: Preprint And Has Not Been Certified By Peer Review
DOI:
IF:
Application: WB
Reactivity: Rat
Publish date: 2024 Jul
-
HNRNP I promotes IRAK1 degradation to reduce podocyte apoptosis and inflammatory response alleviating renal injury in diabetic nephropathy
Journal: Immunobiology
DOI:
IF: 2.5
Application: WB
Reactivity: Human
Publish date: 2024 Jul
-
IL-17A regulates collagen synthesis after autophagy in bronchial fibroblasts through the PI3K/AKT/mTOR pathway
Journal: Preprint And Has Not Been Certified By Peer Review
DOI:
IF:
Application: WB
Reactivity: Rat
Publish date: 2024 Jan
-
Sophocarpine inhibits the progression of glioblastoma via PTEN/PI3K/Akt signaling pathway
Journal: American Journal Of Cancer Research
DOI: 10.62347/SQJB1901
IF: 3.6
Application: WB
Reactivity: Human
Publish date: 2024 Aug
-
Evodiamine Inhibits the Progression of Esophageal Aquamous Cell Carcinoma via Modulating PI3K/AKT/mTOR Pathway
Journal: Preprint And Has Not Been Certified By Peer Review
DOI: 10.21203/rs.3.rs-4133300/v1
IF:
Application: WB
Reactivity: Human,Mouse
Publish date: 2024 Apr
-
The mechanism of action of paeoniae radix rubra-angelicae sinensis radix drug pair in the treatment of rheumatoid arthritis through PI3K/AKT/NF-κB signaling pathway
Journal: Frontiers In Pharmacology
DOI:
IF: 5.988
Application: WB,IHC-P
Reactivity: Rat
Publish date: 2023 Mar
-
A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway
Journal: Journal Of Ethnopharmacology
DOI:
IF: 5.4
Application: WB
Reactivity: Human
Publish date: 2023 Mar
-
Investigating the Mechanism of Action of Schisandra chinensis Combined with Coenzyme Q10 in the Treatment of Heart Failure Based on PI3K-AKT Pathway
Journal: Drug Design Development And Therapy
DOI:
IF: 4.319
Application: WB
Reactivity: Rat
Publish date: 2023 Mar
-
Mechanisms of action underlying the effect of Tongsaimai on wound healing based on experimental and network pharmacology
Journal: Journal Of Ethnopharmacology
DOI:
IF: 5.195
Application: WB
Reactivity: Mouse
Publish date: 2023 Jul
-
Carvedilol exhibits anti-acute T lymphoblastic leukemia effect in vitro and in vivo via inhibiting β-ARs signaling pathway
Journal: Biochemical And Biophysical Research Communications
DOI:
IF: 3.1
Application: WB
Reactivity: Human
Publish date: 2023 Jan
-
Knockdown of LMNA inhibits Akt/β-catenin-mediated cell invasion and migration in clear cell renal cell carcinoma cells
Journal: Cell Adhesion & Migration
DOI:
IF: 3.2
Application: WB
Reactivity: Human
Publish date: 2023 Dec
-
Comprehensive analysis of clinical prognosis and biological significance of CNIH4 in cervical cancer
Journal: Cancer Medicine
DOI: 10.1002/cam4.6734
IF: 4
Application:
Reactivity:
Publish date: 2023 Dec
-
Downregulation of PIK3IP1 in retinal microglia promotes retinal pathological neovascularization via PI3K-AKT pathway activation
Journal: Scientific Reports
DOI:
IF:
Application: WB
Reactivity: Human
Publish date: 2023 Aug
-
TNFSF14/LIGHT promotes cardiac fibrosis and atrial fibrillation vulnerability via PI3Kγ/SGK1 pathway-dependent M2 macrophage polarisation
Journal: Journal Of Translational Medicine
DOI:
IF: 7.4
Application: WB
Reactivity: Mouse
Publish date: 2023 Aug
-
Ozone causes depressive-like response through PI3K/Akt/GSK3β pathway modulating synaptic plasticity in young rats
Journal: Ecotoxicology And Environmental Safety
DOI: 10.1016/j.ecoenv.2022.114171
IF: 7.129
Application: WB
Reactivity: Rat
Publish date: 2022 Oct
-
A liposome-based combination strategy using doxorubicin and a PI3K inhibitor efficiently inhibits pre-metastatic initiation by acting on both tumor cells and tumor-associated macrophages
Journal: Nanoscale
DOI:
IF: 7.790
Application: FC
Reactivity: Mouse
Publish date: 2022 Mar
-
Nickel nanoparticles affect the migration and invasion of HTR-8/SVneo cells by downregulating MMP2 through the PI3K/AKT pathway
Journal: Toxicology In Vitro
DOI:
IF: 3.2
Application: WB
Reactivity: Human
Publish date: 2022 Apr
-
Metformin Prevents Follicular Atresia in Aging Laying Chickens through Activation of PI3K/AKT and Calcium Signaling Pathways
Journal: Oxidative Medicine And Cellular Longevity
DOI:
IF: 5.076
Application: WB,IHC-P
Reactivity: Chicken
Publish date: 2020 Nov
-
The age-related changes and differences in energy metabolism and glutamate-glutamine recycling in the d-gal-induced and naturally occurring senescent astrocytes in vitro.
Journal: Experimental Gerontology
DOI:
IF: 3.224
Application: WB
Reactivity: Rat
Publish date: 2019 Apr
Products with the same target and pathway
PI 3 Kinase p85 alpha Mouse Monoclonal Antibody [A3-D0]
Application: WB,IF-Cell
Reactivity: Human
Conjugate: unconjugated
PI 3 Kinase p85 alpha Mouse Monoclonal Antibody [L3-D6]
Application: WB,IHC-P,IF-Cell,IF-Tissue
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
PI 3 Kinase p85 alpha Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated